These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 21258338)

  • 1. A multistage tuberculosis vaccine that confers efficient protection before and after exposure.
    Aagaard C; Hoang T; Dietrich J; Cardona PJ; Izzo A; Dolganov G; Schoolnik GK; Cassidy JP; Billeskov R; Andersen P
    Nat Med; 2011 Feb; 17(2):189-94. PubMed ID: 21258338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection.
    Lin PL; Dietrich J; Tan E; Abalos RM; Burgos J; Bigbee C; Bigbee M; Milk L; Gideon HP; Rodgers M; Cochran C; Guinn KM; Sherman DR; Klein E; Janssen C; Flynn JL; Andersen P
    J Clin Invest; 2012 Jan; 122(1):303-14. PubMed ID: 22133873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation.
    Ma J; Teng X; Wang X; Fan X; Wu Y; Tian M; Zhou Z; Li L
    EBioMedicine; 2017 Aug; 22():143-154. PubMed ID: 28711483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa.
    Perez-Martinez AP; Ong E; Zhang L; Marrs CF; He Y; Yang Z
    Infect Genet Evol; 2017 Nov; 55():244-250. PubMed ID: 28941991
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
    Lu JB; Chen BW; Wang GZ; Fu LL; Shen XB; Su C; Du WX; Yang L; Xu M
    J Microbiol Immunol Infect; 2015 Dec; 48(6):597-603. PubMed ID: 24863497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of latency-associated antigens in tuberculosis vaccines.
    Yousefi Avarvand A; Khademi F; Tafaghodi M; Ahmadipour Z; Moradi B; Meshkat Z
    Indian J Tuberc; 2019 Oct; 66(4):487-491. PubMed ID: 31813436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.
    Luabeya AK; Kagina BM; Tameris MD; Geldenhuys H; Hoff ST; Shi Z; Kromann I; Hatherill M; Mahomed H; Hanekom WA; Andersen P; Scriba TJ; ; Schoeman E; Krohn C; Day CL; Africa H; Makhethe L; Smit E; Brown Y; Suliman S; Hughes EJ; Bang P; Snowden MA; McClain B; Hussey GD
    Vaccine; 2015 Aug; 33(33):4130-40. PubMed ID: 26095509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
    Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
    Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models.
    Ahn SS; Jeon BY; Kim KS; Kwack JY; Lee EG; Park KS; Sung YC; Cho SN
    Gene Ther; 2012 May; 19(5):570-5. PubMed ID: 21956689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.
    Chang-hong S; Xiao-wu W; Hai Z; Ting-fen Z; Li-Mei W; Zhi-kai X
    DNA Cell Biol; 2008 Apr; 27(4):199-207. PubMed ID: 18163878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
    Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
    Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.